Details for 2018798594
Up to date per 02.04.2026
Actions
Details for 2018798594
Granted/Registered
European Patent
15.04.2020 A
27.09.2023 B1
12.05.2017
US
201762505734 P
04.08.2017
US
201762541612 P
07.12.2017
US
201715835219
A61K 38/13 20060101AFI20210210BHEP
Owner
Aurinia Pharmaceuticals Inc.4464 Markham Street, Suite 1203 Victoria, BC V8Z 7X8CA
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
SOLOMONS, Neilc/o Aurinia Pharmaceuticals Inc. 1203, 4464 Markham Street Victoria, British Columbia V8Z 7X8CA
HUIZINGA, Robert Bc/o Aurinia Pharmaceuticals Inc. 1203, 4464 Markham Street Victoria, British Columbia V8Z 7X8CA
Information about Fees